BioTechX USA 2025 hosted 40+ start-ups from across the biotech and genomics space, working on cutting-edge innovative platform technologies and pioneering AI solutions. For 2026, we are debuting our new start-up and innovation track for investors and pre-series A companies.
This is a unique opportunity to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals.
Questions?
Contact Manav Patel
Pre-Series A funding & fewer than 15 employees.
Your company must be 5 years old or younger.
2x attendance passes to the full 3-day congress.
3ft² exhibition pod with graphics provided.
Pre-event marketing on our website and social media.
Investor matching and access to the Terrapinn App.
The Start-Up Plus package provides a 10-minute on-stage pitching slot to present your value proposition deck to our portfolio of investors. We aim to provide a varied portfolio of VCs, Accelerators, and Angels.